Running title: p53 binding and transactivation after diverse stresses SUPPLEMENTARY MATERIALS Supplementary figure legends Supplementary Figure 1. ChIP-qPCR validation of p53 binding sites identified from ChIP-Seq data. (A) Western blot of p53 in U2OS nuclear extracts following 24 hr of no treatment (NT), 0.1% DMSO, 0.6 µg/ml Doxorubicin (DXR), or 10 µM Nutlin. Lamin B is the loading control. Presented is an overexposed film to assess the DMSO effect on p53 nuclear levels. (B) U2OS cell cycle profile determined by FACS analysis 24h after treatments (C) Venn diagram illustrating unique and overlapping p53 ChIP-seq binding sites among the 4 different conditions: NT, DMSO, DXR, Nutlin. (D) ChIP-qPCR of select p53 binding regions in U2OS cells using an antibody against p53 or mouse IgG following 24 hr of NT, DMSO, DXR, or Nutlin treatment. The y-axis represents the p53 or IgG enrichment relative to input. Error bars represent SEM of duplicate experiments. (E) ChIP-qPCR of 36 selected p53 binding regions (full-sites with no spacer between decamers and half sites or full-sites with spacers) as well as two unbound control
. Sequenced reads in ChIP-seq study. Supplementary Table 2 . List of selected p53 binding regions and associated genes for ChIP-qPCR and qPCR-RT validation Supplementary Table 3 . Transcription factor binding sites over-represented in the p53 ChIP-Seq peaks. Other transcription factor motifs identified by Transfac that are associated with p53 binding peaks significantly more frequently than by chance. All had E-values <0.1.
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